Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Guillaume Martin-Blondel and Pierre Delobel.
Connection Strength

0.458
  1. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clin Infect Dis. 2020 12 31; 71(11):2962-2964.
    View in: PubMed
    Score: 0.230
  2. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. BMC Pharmacol Toxicol. 2021 03 11; 22(1):14.
    View in: PubMed
    Score: 0.058
  3. Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study. Fundam Clin Pharmacol. 2021 Feb; 35(1):194-203.
    View in: PubMed
    Score: 0.057
  4. Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort. Rev Med Interne. 2020 Nov; 41(11):732-740.
    View in: PubMed
    Score: 0.057
  5. COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):1004-1006.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.